Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.3050
-0.0050 (-1.61%)
Feb 9, 2026, 3:49 PM EST
Theralase Technologies Employees
Theralase Technologies had 20 employees as of December 31, 2017. The number of employees decreased by 14 or -41.18% compared to the previous year.
Employees
20
Change
-14
Growth
-41.18%
Revenue / Employee
50.05K CAD
Profits / Employee
-217.66K CAD
Market Cap
80.83M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2017 | 20 | -14 | -41.18% |
| Dec 31, 2015 | 34 | - | - |
Theralase Technologies News
- 6 days ago - Theralase(R) Provides Update on Bladder Cancer Clinical Study - Newsfile Corp
- 4 weeks ago - Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer - Newsfile Corp
- 4 weeks ago - Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer - Business Wire
- 6 weeks ago - Theralase(R) Closes $1.3 M Non-Brokered Private Placement - Newsfile Corp
- 2 months ago - Theralase Technologies (TLTFF) Launches C$2M Private Placement - GuruFocus
- 2 months ago - Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing - Newsfile Corp
- 2 months ago - Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study - Newsfile Corp
- 3 months ago - Theralase(R) Investor Conference Call Reminder - Newsfile Corp